Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adverse reaction to disopyramide.

J B Dibble, N R Webster

    Postgraduate Medical Journal
    |September 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Intravenous disopyramide, used for supraventricular tachycardia, can worsen ventricular dysrhythmia, leading to hypotension and potentially myocardial infarction. This case highlights the risks associated with disopyramide use in cardiac patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacological activation of endogenous protective pathways against oxidative stress under conditions of sepsis.

    British journal of anaesthesia·2015
    Same author

    Low zinc and selenium concentrations in sepsis are associated with oxidative damage and inflammation.

    British journal of anaesthesia·2015
    Same author

    Efficacy of dexmedetomidine compared with midazolam for sedation in adult intensive care patients: a systematic review.

    British journal of anaesthesia·2013
    Same author

    Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis.

    British journal of anaesthesia·2013
    Same author

    Role of microparticles in sepsis.

    British journal of anaesthesia·2012
    Same author

    The influence of surgery on the onset of symptomatic coronary artery disease.

    Anaesthesia·2012
    Same journal

    Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

    Postgraduate medical journal·2026
    Same journal

    Diagnostic reasoning in clinical neurology: a comprehensive primer.

    Postgraduate medical journal·2026
    Same journal

    Asthma therapy over 100 years.

    Postgraduate medical journal·2026
    Same journal

    Transformation of trauma and orthopaedics across the six industrial revolutions: from mechanization to artificial intelligence applications in enhancing patient care.

    Postgraduate medical journal·2026
    Same journal

    Increased food prices and changes in food consumption behavior: an early precursor to malnutrition, and widespread food insecurity among the Egyptian population.

    Postgraduate medical journal·2026
    Same journal

    Acute kidney injury in rhabdomyolysis defined by serum creatine kinase ≥1000 IU/L: association with creatine kinase levels.

    Postgraduate medical journal·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Clinical Pharmacology

    Background:

    • Supraventricular tachycardia (SVT) is a common cardiac arrhythmia requiring prompt treatment.
    • Disopyramide is an antiarrhythmic medication sometimes used to manage SVT.

    Observation:

    • A patient receiving intravenous disopyramide for SVT developed a more severe ventricular dysrhythmia.
    • This adverse event was associated with significant hypotension.

    Findings:

    • The observed ventricular dysrhythmia and hypotension following disopyramide administration were likely linked.
    • These complications potentially contributed to the development of a myocardial infarction in the patient.

    Implications:

    • Clinicians should be aware of the potential proarrhythmic risk of disopyramide, especially in patients with compromised cardiac function.

    Related Experiment Videos

  • Careful monitoring for adverse effects like hypotension and worsening dysrhythmia is crucial when administering intravenous disopyramide.